Aldeyra Therapeutics, Inc. , a biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases.
Aldeyra Therapeutics stock last closed at $1.21, down 1.23% from the previous day, and has decreased 75.66% in one year. It has underperformed other stocks in the Biotechnology industry by 0.54 percentage points. Aldeyra Therapeutics stock is currently +12.62% from its 52-week low of $1.07, and -79.68% from its 52-week high of $5.93.
As of Sep 25, 2026, there are 60.33M shares of ALDX outstanding. The market capitalization of ALDX is $72.69M. In the last 24 hours, 644,000 ALDX shares were traded.
You will need an online brokerage account in order to access the NASDAQ market and buy ALDX stock.
Based on our research, eToro is the best place to buy stocks. eToro gives you:
Get $10 towards your purchase of shares by opening an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've picked the right brokerage, you need to fill out some personal information so you are able to invest in ALDX stock today.
Now that you've created your account on one of the best stock market apps, your next step is to transfer the money for your investment:
Check out the walkthrough below if you need help transferring money into your brokerage account.
Once you have identified the best place to buy Aldeyra Therapeutics stock, it's important to research their stock before you buy, so you can comprehend the risk and opportunity.
WallStreetZen was designed to help average investors do more accurate fundamental analysis in less time.
You can see all of the due diligence checks on ALDX's stock page.
You can use a variety of different financial metrics, analyses, models, and charts to gauge ALDX's intrinsic value.
Using relative valuations methods:
You can access more valuation analysis on ALDX's stock here.
You can dive deeper into what analysts are forecasting on the Aldeyra Therapeutics stock forecast page.
In the last year, executives and large shareholders at ALDX have bought more shares than they have sold.
Todd C. Brady, President and CEO of ALDX, was the latest ALDX insider to buy. They bought $418,500.00 worth of ALDX stock on Jun 3, 2026.
Research more about who owns ALDX shares here.
No, Aldeyra Therapeutics doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
There are two primary types of orders:
Hit the Open Trade button and eToro will execute your order.
If you want additional help with buying stocks on eToro, click the how to video below:
Now that you own some ALDX stock, you'll want to keep up with your shares.
Put ALDX on a watchlist to keep tabs on your ALDX stock.
To reiterate, here are the 6 steps to buy stock in Aldeyra Therapeutics:
If you need a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to watch your new investment in Aldeyra Therapeutics, click the button below.